CONMED CNMD Amortization expense related to capitalized debt issuance costs
Amortization expense related to capitalized debt issuance costs at other companies
Other financials
Where this comes from
Reported directly by CONMED in its filing.
Tagged under the XBRL concept us-gaap:AmortizationOfFinancingCosts.
The official record: CONMED’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about CONMED's amortization expense related to capitalized debt issuance costs.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is CONMED's amortization expense related to capitalized debt issuance costs?
- CONMED (CNMD) reported amortization expense related to capitalized debt issuance costs of $1.28M in Q1 2026.
- How has CONMED's amortization expense related to capitalized debt issuance costs changed year-over-year?
- CONMED's amortization expense related to capitalized debt issuance costs decreased by 11.6% year-over-year, from $1.44M to $1.28M.
- What is the long-term trend for CONMED's amortization expense related to capitalized debt issuance costs?
- Over 4 years (2021 to 2025), CONMED's amortization expense related to capitalized debt issuance costs has grown at a 10.9% compound annual growth rate (CAGR), from $3.73M to $5.65M.